Patients Stopping Weight-Loss Jabs Regain Weight Far More Rapidly Than Those on Conventional Diets

A recent study indicates that individuals who stop using blockbuster slimming jabs like Mounjaro or Wegovy may regain lost weight at a significantly accelerated pace than those who halt traditional diet and exercise programs.

Findings released in a leading health publication points out that while obese people often shed a large proportion of their total mass while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month once they quit.

"Individuals purchasing such drugs should be aware of the risk of fast rebound weight gain when the treatment is stopped," stated lead investigator Dr. Susan Jebb.

This pace of regain implies a reversion to pre-treatment mass in about 18 months.

Weighing Treatments

The research, which looked at 37 of studies involving over 9,000 of participants, contrasted the outcomes of the injectable medications with other pills.

Scientists note that people who shed pounds through diet and exercise usually experience a more gradual weight regain—perhaps 0.1 kg a month—once they finish.

The Reason for the Fast Rebound

Nutrition scientists believe the way of the jabs accounts for the heightened regain.

These medications copy a natural hormone called glucagon-like peptide-1, which helps regulate hunger.

"Artificially providing the hormone levels far above than the body's typical production could lead to the system to generate a reduced amount of its endogenous GLP-1, and could lessen responsiveness to its actions," said Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this GLP-1 'fix' leads to appetite is no longer kept in check, making binge eating a significant risk."

A Lifelong Disease?

Health authorities recommend the jabs for people with obesity-related medical conditions, alongside recommended diet and exercise modifications.

Many experts contend that, given the high risk of weight regain, the therapy is often long-term.

This view is supported by drug manufacturers, who note that the results "underscore the long-term nature of obesity," comparing it to managing diseases like hypertension.

Patient Experiences

People who have come off the jabs report a intense resurgence of hunger.

"I experienced something activating and you become extremely hungry," described a patient.

This difficulty is exacerbated if users have not established lasting lifestyle or habit modifications during therapy.

Widespread Use

Survey data show that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with interest remaining high.

• Adoption is more common among women compared to males.
• The 40s and 50s demographic shows the highest usage rates.
• A large proportion obtain the medications through private healthcare rather than the NHS.

In conclusion, researchers stress that while the jabs are effective agents for shedding pounds, they are not a standalone solution and lasting health benefits hinges on integrated behavioural changes.